Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0049 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.019 | 0.9 |